The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 901–1,000 of 1,072
Testing thousands of nanoparticles in vivo using DNA barcodes
Lokugamage, M. P., Sago, C. D., & Dahlman, J. E. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.08.001 · Cited by 83
Kizer, M. E., Deng, Y., Kang, G., Mikael, P. E., Wang, X., & Chung, A. J. (2019) · Lab on a Chip · doi:10.1039/c9lc00041k · Cited by 88
An Efficient Electroporation Protocol for the Genetic Modification of Mammalian Cells
Chicaybam, L., Barcelos, C., Peixoto, B., Carneiro, M., Limia, C. E. G., Redondo, P., de Morais, C. C. P. D. L., Paraguassú-Braga, F. H., de Vasconcelos, Z. F. M., Barros, L. R. C., et al. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00099 · Cited by 100
“The recent description of the CRISPR/Cas9 system as an efficient tool to edit the genome of cells has clear implications for basic cell biology studies and gene therapy protocols (Doudna and Charpentier, 2014).”
BackgroundChallenges and Perspectives in Homology-Directed Gene Targeting in Monocot Plants
Van Vu, T., Sung, Y. W., Kim, J., Doan, D. T. H., Tran, M. T., & Kim, J.-Y. (2019) · Rice · doi:10.1186/s12284-019-0355-1 · Cited by 83
“Repair pathways in animals as well as plants have been extensively reviewed elsewhere (Belhaj et al. 2013; Hsu et al. 2014; Doudna and Charpentier 2014; Bortesi and Fischer 2015; Rees and Liu 2018).”
BackgroundOptimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach
Freitag, F., & Wagner, E. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.03.005 · Cited by 92
Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system
Rahimi, H., Salehiabar, M., Charmi, J., Barsbay, M., Ghaffarlou, M., Razlighi, M. R., Davaran, S., Khalilov, R. I., Sugiyama, M., Nosrati, H., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100895 · Cited by 84
Broadening the GMO risk assessment in the EU for genome editing technologies in agriculture
Kawall, K., Cotter-Howells, J. D., & Then, C. (2020) · Environmental Sciences Europe · doi:10.1186/s12302-020-00361-2 · Cited by 94
Nelson, J. P., Selin, C. L., & Scott, C. T. (2021) · Journal of Responsible Innovation · doi:10.1080/23299460.2021.1957579 · Cited by 90
Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development
Wu, K. Y., Kulbay, M., Toameh, D., Xu, A. Q., Kalevar, A., & Tran, S. D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020685 · Cited by 92
Singh, V. V., Naseer, A., Mogilicherla, K., Trubin, A., Zabihi, K., Roy, A., Jakuš, R., & Erbilgin, N. (2024) · Reviews in Environmental Science and Bio/Technology · doi:10.1007/s11157-024-09692-5 · Cited by 94
“This process, known as gene “knock-out,” is a reliable method for identifying genes of interest or gaining deeper insights into genome complexities (Doudna and Charpentier 2014; Jiang and Doudna 2017).”
Anaphase A: Disassembling Microtubules Move Chromosomes toward Spindle Poles
Asbury, C. (2017) · Biology · doi:10.3390/biology6010015 · Cited by 72
“Probably more cases that do not fit the ‘normal’ picture will emerge as more transcriptomes and genomes are sequenced, and as new genome-editing technologies, such as CRISPR [55], facilitate live imaging of fluorescent-marked spindles in less-studied cell types”
BackgroundChen, J., Lai, Y., Wang, L., Zhai, S., Zou, G., Zhou, Z., Cui, C., & Wang, S. (2017) · Scientific Reports · doi:10.1038/srep45763 · Cited by 90
Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design
Beitelshees, M., Hill, A. B., Jones, C. H., & Pfeifer, B. A. (2018) · Materials · doi:10.3390/ma11071086 · Cited by 93
“This is possible due to technologies such as CRISPR (clustered regularly interspaced short palindromic repeats), which allows for the alteration of any target gene [127].”
MethodGenomic approaches for studying crop evolution
Schreiber, M., Stein, N., & Mascher, M. (2018) · Genome biology · doi:10.1186/s13059-018-1528-8 · Cited by 86
“Genome editing with CRISPR-Cas9 technology [169] has enriched the plant geneticist’s toolkit [170].”
BackgroundTargeted Gene Disruption in Pacific Oyster Based on CRISPR/Cas9 Ribonucleoprotein Complexes
Yu, H., Li, H., Li, Q., Xu, R., Yue, C., & Du, S. (2019) · Marine Biotechnology · doi:10.1007/s10126-019-09885-y · Cited by 92
Lin, W. T., Ortega, D. L., Caputo, V., & Lusk, J. L. (2019) · Food Quality and Preference · doi:10.1016/j.foodqual.2019.03.007 · Cited by 91
Deng, Z.-L., Gottschick, C., Bhuju, S., Masur, C., Abels, C., & Wagner‐Döbler, I. (2018) · mSphere · doi:10.1128/mspheredirect.00262-18 · Cited by 90
“foreign DNA and has been developed into a universal tool for genome editing (46).”
MethodEndogenous Fluorescence Tagging by CRISPR
Bukhari, H., & Müller, T. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.08.004 · Cited by 82
Sanjurjo-Soriano, C., Erkilic, N., Baux, D., Mamaeva, D., Hamel, C. P., Meunier, I., Roux, A.-F., & Kalatzis, V. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.016 · Cited by 79
Disease mechanisms and gene therapy for Usher syndrome
Géléoc, G. S. G., & El-Amraoui, A. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107932 · Cited by 86
Mo, F., Duan, S., Jiang, X., Yang, X., Hou, X., Shi, W., Jumbo, J. C. C., Liu, A., Yin, S., Wang, W., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00462-1 · Cited by 86
Cryptosporidium spp. Diagnosis and Research in the 21st Century
O'Leary, J. K., Sleator, R. D., & Lucey, B. (2021) · Food and Waterborne Parasitology · doi:10.1016/j.fawpar.2021.e00131 · Cited by 98
“…the aforementioned CRISPR/Cas9 genetic modification of C. parvum may prove critical in the development of vaccines and more effective drug therapies, particularly given the utility of gene ablation in identifying alternative treatment strategies (Doudna and Charpentier, 2014; Vinayak et al., 2015).”
BackgrounddCas9-based gene editing for cleavage-free genomic knock-in of long sequences
Wang, C., Qu, Y., Cheng, J. K. W., Hughes, N. W., Zhang, Q., Wang, M., & Cong, L. (2022) · Nature Cell Biology · doi:10.1038/s41556-021-00836-1 · Cited by 90
Characterization of a thermostable Cas13 enzyme for one-pot detection of SARS-CoV-2
Mahas, A., Maršić, T., Masson, M. L.-P., Wang, Q., Aman, R., Zheng, C., Ali, Z., Alsanea, M. S., Al-Qahtani, A. A., Ghanem, B., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118260119 · Cited by 86
The role and application of bioinformatics techniques and tools in drug discovery
Zhang, S., Liu, K., Liu, Y., Hu, X., & Gu, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1547131 · Cited by 110
“In top-down proteomics, complete protein molecules are analyzed directly by mass spectrometry (Doudna and Charpentier, 2014); In the bottom-up approach, the protein sample is fi rst hydrolyzed and digested into peptides, which are then analyzed in a mass spectrometer (Wang et al., 2014).”
Liu, P., Wen, S., Zhu, S., Hu, X., & Wang, Y. (2025) · Processes · doi:10.3390/pr13030916 · Cited by 96
Molecular tools for gene manipulation in filamentous fungi
Wang, S., Chen, H., Tang, X., Zhang, H., Chen, W., & Chen, Y. Q. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8486-z · Cited by 86
“CRISPR/Cas systems in bacteria and archaebacteria play a biological role in adaptive immunity systems against foreign DNA (Ran et al. 2013a; Doudna and Charpentier 2014).”
BackgroundCRISPR–Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity
Faure, G., Makarova, K. S., & Koonin, E. V. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.08.030 · Cited by 81
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Ghosh, D., Venkataramani, P., Nandi, S., & Bhattacharjee, S. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0726-0 · Cited by 76
“The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated nuclease 9 (Cas9) is a technology which is scalable, affordable and easy to engineer [6, 7].”
BackgroundEvaluating strategies for reversing CRISPR-Cas9 gene drives
Vella, M. R., Gunning, C. E., Lloyd, A. L., & Gould, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-10633-2 · Cited by 80
“Introduction Recent work has employed the CRISPR-Cas9 system[8, 14] to create homing drives (HD) that increase the frequency of genetic constructs in a population even if they lower the fitness of individuals that carry them[11].”
BackgroundRaveux, A., Vandormael‐Pournin, S., & Cohen‐Tannoudji, M. (2017) · Scientific Reports · doi:10.1038/srep42661 · Cited by 84
Splicing heterogeneity: separating signal from noise
Wan, Y., & Larson, D. R. (2018) · Genome Biology · doi:10.1186/s13059-018-1467-4 · Cited by 80
Development and Application of CRISPR/Cas in Microbial Biotechnology
Ding, W., Zhang, Y., & Shi, S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00711 · Cited by 87
“The PAM of the most commonly used SpCas9 (Cas9 from Streptococcus pyogenes) is ‘NGG,’ which occurs once every 8 bp on average within the genome, allowing targeting on most genes of interest (Doudna and Charpentier, 2014; Hsu et al., 2014).”
MethodAn optimized CRISPR/Cas9 approach for precise genome editing in neurons
Fang, H., Bygrave, A. M., Roth, R. H., Johnson, R. C., & Huganir, R. L. (2021) · eLife · doi:10.7554/elife.65202 · Cited by 80
Nazir, A., Hussain, F. H. N., & Raza, A. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1511149 · Cited by 98
Efficient Gene Disruption in Cultured Primary Human Endothelial Cells by CRISPR/Cas9
Abrahimi, P., Chang, W. G., Kluger, M. S., Qyang, Y., Tellides, G., Saltzman, W. M., & Pober, J. S. (2015) · Circulation Research · doi:10.1161/circresaha.117.306290 · Cited by 86
The societal opportunities and challenges of genome editing
Carroll, D., & Charo, R. A. (2015) · Genome biology · doi:10.1186/s13059-015-0812-0 · Cited by 95
“Introduction The genome editing technologies that are causing a current stir began life quietly in the 1990s, but are enjoying a remarkable surge, largely owing to the introduction of the CRISPR-Cas tools in 2012 [1–3].”
BackgroundGenome Editing and Its Applications in Model Organisms
Ma, D., & Liu, F. (2015) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.12.001 · Cited by 91
“Until now, the CRISPR/Cas system not only improves basic research but also has potential applications in gene therapy through gene repair, gene disruption, and programmable RNA targeting [32].”
BackgroundCas14: Big Advances from Small CRISPR Proteins
Savage, D. F. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00035 · Cited by 88
Behavior-related gene regulatory networks: A new level of organization in the brain
Sinha, S., Jones, B. M., Traniello, I. M., Bukhari, S. A., Halfon, M. S., Hofmann, H. A., Huang, S., Katz, P. S., Keagy, J., Lynch, V. J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921625117 · Cited by 85
Long Non-Coding RNAs in Cancer and Development: Where Do We Go from Here?
Hämmerle, M., & Gutschner, T. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16011395 · Cited by 82
The CRISPR-Cas system in Enterobacteriaceae
Medina-Aparicio, L., Dávila‐Ramos, S., Rebollar-Flores, J. E., Calva, E., & Hernández-Lucas, I. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty002 · Cited by 86
Qiao, J., Sun, W., Lin, S., Jin, R., Ma, L., & Liu, Y. (2019) · Chemical Communications · doi:10.1039/c9cc00010k · Cited by 79
Nguyen, C. T., Dhakal, D., Pham, V. T. T., Nguyen, H. T., & Sohng, J. K. (2020) · Microorganisms · doi:10.3390/microorganisms8040616 · Cited by 92
Oberkofler, V., & Bäurle, I. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac113 · Cited by 86
“Clustered regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated 9 (Cas9) provides a powerful method to selectively manipulate individual loci by targeting them with the help of specific single-guide RNAs (sgRNAs) (Doudna and Charpentier, 2014; Kumlehn et al., 2018).”
Yadav, A. K., Butler, C. D., Ah, Y., Patil, A. A., Lloyd, A. L., & Scott, M. J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2301525120 · Cited by 93
“CRISPR/Cas, which refers to Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein, was originally derived from the immune systems of bacteria and archaea (19, 20).”
Iyombe-Engembe, J.-P., Ouellet, D. L., Barbeau, X., Rousseau, J., Chapdelaine, P., Lagüe, P., & Tremblay, J. P. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.58 · Cited by 92
C., H. M. S., Wu, S. L., Bennett, J. B., & Marshall, J. M. (2019) · Methods in Ecology and Evolution · doi:10.1111/2041-210x.13318 · Cited by 80
McCullough, K. T., Boye, S. L., Fajardo, D., Calabro, K., Peterson, J. J., Strang, C. E., Chakraborty, D., Gloskowski, S., Haskett, S., Samuelsson, S., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.193 · Cited by 79
Rahman, M. K., & Rahman, M. S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181943 · Cited by 79
In Vivo Genome Editing as a Therapeutic Approach
Ho, B. X., Loh, S. J. H., Chan, W., & Soh, B.-S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092721 · Cited by 83
“A bacterial scaffold RNA known as the trans-activating crRNA (tracrRNA) is also being transcribed to assist in the association of crRNA with Cas9, which in turn guides the endonuclease to its complimentary DNA target site [23] (Figure 1D).”
BackgroundSynthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing
Tang, H., Zhao, X., & Jiang, X. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.03.001 · Cited by 83
“These genome-editing techniques used for gene knock-out or knock-in predominately include meganucleases, zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the CRISPR-Cas system [4-7].”
BackgroundGenetic Causation in Complex Regulatory Systems: An Integrative Dynamic Perspective
DiFrisco, J., & Jaeger, J. (2020) · BioEssays · doi:10.1002/bies.201900226 · Cited by 86
CRISPR-Cas-Based Engineering of Probiotics
Liu, L., Helal, S. E., & Peng, N. (2023) · BioDesign Research · doi:10.34133/bdr.0017 · Cited by 94
“Among these technologies, Cas9-and Cas12-based genome engineering have been extensively studied and widely applied because of their high specificity, efficiency, and multiple functions [29,30].”
BackgroundEthical Issues in Genome Editing using Crispr/Cas9 System
E, R. (2016) · Journal of Clinical Research & Bioethics · doi:10.4172/2155-9627.1000266 · Cited by 74
Zerbini, F., Zanella, I., Fraccascia, D., König, E., Irene, C., Frattini, L. F., Tomasi, M., Fantappiè, L., Ganfini, L., Caproni, E., et al. (2017) · Microbial Cell Factories · doi:10.1186/s12934-017-0681-1 · Cited by 87
Programmable DNA looping using engineered bivalent dCas9 complexes
Hao, N., Shearwin, K. E., & Dodd, I. B. (2017) · Nature Communications · doi:10.1038/s41467-017-01873-x · Cited by 77
Expanding the genome-targeting scope and the site selectivity of high-precision base editors
Tan, J., Zhang, F., Karcher, D., & Bock, R. (2020) · Nature Communications · doi:10.1038/s41467-020-14465-z · Cited by 75
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection
Wollebo, H. S., Bellizzi, A., Kaminski, R., Hu, W., White, M. K., & Khalili, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136046 · Cited by 77
A simple, flexible and high‐throughput cloning system for plant genome editing via CRISPR‐Cas system
Kim, H., Kim, S., Ryu, J., Choi, M. K., Kweon, J., Kang, B., Ahn, H., Bae, S., Kim, J., Kim, J., et al. (2016) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12474 · Cited by 88
“Type II CRISPR-Cas system from Streptococcus pyogenes has been intensively studied and modified to induce targeted mutagenesis in animals and plants (Doudna and Charpentier 2014; Hsu et al. 2014; KimandKim 2014; Baltes and Voytas 2015).”
BackgroundCas9-nickase–mediated genome editing corrects hereditary tyrosinemia in rats
Shao, Y., Wang, L., Guo, N., Wang, S., Yang, L., Li, Y., Wang, M., Yin, S., Han, H., Zeng, L., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000347 · Cited by 75
“Site-specific DSBs are repaired simultaneously in the cells by two major mechanisms, the error-prone nonhomologous end-joining (NHEJ) pathway or the high fidelity homology-directed repair (HDR) pathway (6).”
BackgroundComparative analysis of single-stranded DNA donors to generate conditional null mouse alleles
Lanza, D. G., Gaspero, A., Lorenzo, I., Liao, L., Zheng, P., Wang, Y., Deng, Y., Cheng, C., Zhang, C., Rasband, M. N., et al. (2018) · BMC Biology · doi:10.1186/s12915-018-0529-0 · Cited by 80
Discovery and Characterization of Cas9 Inhibitors Disseminated across Seven Bacterial Phyla
Uribe, R. V., van der Helm, E., Misiakou, M.-A., Lee, S.-W., Kol, S., & Sommer, M. O. A. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.003 · Cited by 80
“Type II systems are of particular interest because nucleases such as SpCas9 have been exploited for precise and programmable gene editing with substantial impact on life sciences (Doudna and Charpentier, 2014).”
BackgroundTao, Y., Yi, K., Hu, H., Shao, D., & Li, M. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01925a · Cited by 81
CRISPR/Cas9 technology for improving agronomic traits and future prospective in agriculture
Rao, M. J., & Wang, L. (2021) · Planta · doi:10.1007/s00425-021-03716-y · Cited by 87
“2015; Petolino 2015); however, genome editing using these tools is timeconsuming and laborious, and has least accuracy (Doudna et al. 2014).”
MethodEpigenetic modifications in metabolic memory: What are the memories, and can we erase them?
Chen, Z., & Natarajan, R. D. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00201.2022 · Cited by 92
CRISPR-Cas9 technology: applications and human disease modelling
Torres-Ruiz, R., & Rodríguez, S. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw025 · Cited by 88
Bruder, M. R., Pyne, M. E., Moo‐Young, M., Chung, D. A., & Chou, C.-H. P. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.02128-16 · Cited by 88
“Given the significant advances in genome editing over the past decades, modulating the transcriptome of an organism to derive complex and multigenic phenotypes is still considered challenging (64, 65).”
BackgroundGene delivery nanoparticles to modulate angiogenesis
Kim, J., Mirando, A. C., Popel, A. S., & Green, J. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.11.003 · Cited by 79
Xu, X., Duan, D., & Chen, S.-J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00180-1 · Cited by 77
The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex
Zeng, Y., Cui, Y., Zhang, Y., Zhang, Y., Liang, M., Chen, H., Lan, J., Song, G., & Lou, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1117 · Cited by 79
Tao, Y., Bu, C., Zou, L., Hu, Y., Zheng, Z., & Ouyang, J. (2021) · Biotechnology for Biofuels · doi:10.1186/s13068-021-02067-w · Cited by 82
Classification of CRISPR/Cas system and its application in tomato breeding
Chaudhuri, A., Halder, K., & Datta, A. (2022) · Theoretical and Applied Genetics · doi:10.1007/s00122-021-03984-y · Cited by 85
“2011; Doudna and Charpentier 2014; Burmistrz et al.”
The Promising Nanovectors for Gene Delivery in Plant Genome Engineering
Zhi, H., Zhou, S., Pan, W., Shang, Y., Zeng, Z., & Zhang, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158501 · Cited by 84
“Delivering genes of interest from other species into a plant genome by transient expression or stable integration enables attainment of desired agronomic traits [3].”
BackgroundDeep mutational scanning: A versatile tool in systematically mapping genotypes to phenotypes
Wei, H., & Li, X. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1087267 · Cited by 61
“For DMS studies aimed at endogenous genetic loci, CRISPR-based technologies (Doudna and Charpentier, 2014; Rees and Liu, 2018) are used.”
BackgroundSahel, D. K., Vora, L. K., Saraswat, A. L., Sharma, S., Monpara, J. D., D’souza, A. A., Mishra, D., Tryphena, K. P., Kawakita, S., Khan, S. U., et al. (2023) · Advanced Science · doi:10.1002/advs.202207512 · Cited by 88
Sun, Y., Xu, X., Chen, L., Chew, W. L., Yuan, P., & Miserez, A. (2023) · ACS Nano · doi:10.1021/acsnano.3c02669 · Cited by 82
Hwang, G., Lee, S., Oh, M., Kim, S., Habib, O., Jang, H., Kim, H. S., Kim, Y., Kim, C. H., Kim, S., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01277-5 · Cited by 85
Natanzi, A. S., Poudineh, M., Karimi, E., Khaledi, A., & Kashani, H. H. (2025) · BMC Medicine · doi:10.1186/s12916-025-04323-4 · Cited by 88
“This approach allows for more precise regulation of gene expression, offering a reversible means of controlling biofilm formation without the risk of inducing permanent genetic changes [158].”
Maggio, I., Stefanucci, L., Janssen, J. M., Liu, J., Chen, X., Mouly, V., & Gonçalves, M. A. F. V. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1540 · Cited by 75
“Among these, TALENs seem to display a particularly favorable specificity profile (16), whereas the RGN platform outstands for its simplicity and versatility, especially in multiplexing contexts (17).”
BackgroundMethodLiu, X., Chen, L., Ge, J., Chen, Y., Huang, Z., Hu, J., Wen, C., Li, M., Huang, D., Qiu, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3118 · Cited by 77
Pramanik, S., Sulistio, Y. A., & Heese, K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0214-7 · Cited by 82
Ludman, M., Burgyán, J., & Fátyol, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-01050-6 · Cited by 83
Toward an integrated map of genetic interactions in cancer cells
Rauscher, B., Heigwer, F., Henkel, L., Hielscher, T., Voloshanenko, O., & Boutros, M. (2018) · Molecular Systems Biology · doi:10.15252/msb.20177656 · Cited by 80
“Genome-scale perturbation screens can now be efficiently performed in many cell lines using CRISPR/Cas9 (Barrangou, 2014; Doudna & Charpentier, 2014; Wang et al , 2014; Shalem et al , 2015; Heigwer et al , 2016; Horlbeck et al , 2016) or RNAi (Brummelkamp et al , 2002; Sims et al , 2011; Kampmann…”
In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency
Song, C.-Q., Wang, D., Jiang, T., O'Connor, K., Tang, Q., Cai, L., Li, X., Weng, Z., Yin, H., Gao, G., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.225 · Cited by 75
“CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 has emerged as a transforming genome editing tool with powerful therapeutic applicability.(13,14) Single guide RNA (sgRNA) guides the Cas9 endonuclease to complementary 20 nucleotide genomic sequences that must possess a downstream NGG protospacer…”
BackgroundZimmer, A. M., Pan, Y. K., Chandrapalan, T., Kwong, R. W. M., & Perry, S. F. (2019) · Journal of Experimental Biology · doi:10.1242/jeb.175737 · Cited by 86
Drug Inducible CRISPR/Cas Systems
Zhang, J., Chen, L., Zhang, J., & Wang, Y. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.07.015 · Cited by 69
Seruggia, D., Fernández, A., Cantero, M., Pelczar, P., & Montoliu, L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv375 · Cited by 74
“After more than two decades of basic research (reviewed in (30)), RNA-guided genome editing has emerged as an alternative technique to achieve a wide variety of targeted genetic manipulations and CRISPR–Cas9-mediated mutagenesis has rapidly become the preferred approach in animal transgenesis (31).”
BackgroundPlumage patterns: Ecological functions, evolutionary origins, and advances in quantification
Mason, N. A., & Bowie, R. C. K. (2020) · The Auk · doi:10.1093/auk/ukaa060 · Cited by 81
Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
Kong, H., Ju, E., Yi, K., Xu, W., Lao, Y., Cheng, D., Zhang, Q., Tao, Y., Li, M., & Ding, J. (2021) · Advanced Science · doi:10.1002/advs.202102051 · Cited by 85
Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a
Zhang, J., Li, Z., Guo, C., Guan, X., Avery, L., Banach, D. B., & Liu, C. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202403123 · Cited by 76
Using transgenic reporter assays to functionally characterize enhancers in animals
Kvon, E. Z. (2015) · Genomics · doi:10.1016/j.ygeno.2015.06.007 · Cited by 73
Liang, Y., Iqbal, Z., Wang, J., Xu, L., Xu, X., Ouyang, K., Zhang, H., Lu, J., Duan, L., & Xia, J. (2022) · Biomaterials Science · doi:10.1039/d2bm00480a · Cited by 72
CRISPR mediated somatic cell genome engineering in the chicken
Véron, N., Qu, Z., Kipen, P. A. S., Hirst, C. E., & Marcelle, C. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.08.007 · Cited by 71
CRISPR-based genome editing in wheat: a comprehensive review and future prospects
Kumar, R., Kaur, A., Pandey, A., Mamrutha, H. M., & Singh, G. P. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04761-3 · Cited by 70
Towards a new era in medicine: therapeutic genome editing
Porteus, M. H. (2015) · Genome Biology · doi:10.1186/s13059-015-0859-y · Cited by 69
Nanoparticles for CRISPR–Cas9 delivery
Glass, Z., Li, Y., & Xu, Q. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0158-x · Cited by 69
De novo identification of essential protein domains from CRISPR-Cas9 tiling-sgRNA knockout screens
He, W., Zhang, L., Villarreal, O. D., Fu, R., Bedford, E., Dou, J., Patel, A. Y., Bedford, M. T., Shi, X., Chen, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12489-8 · Cited by 69
“Functional screens using CRISPR/Cas9 techniques facilitates the identification of essential genes on a genome-wide scale 1-4 .”
MethodWhat is needed to eradicate the depression epidemic, and why
Ormel, J., Cuijpers, P., Jorm, A., & Schoevers, R. A. (2020) · Mental Health & Prevention · doi:10.1016/j.mhp.2019.200177 · Cited by 67
RABIF/MSS4 is a Rab-stabilizing holdase chaperone required for GLUT4 exocytosis
Gulbranson, D. R., Davis, E. M., Demmitt, B. A., Ouyang, Y., Ye, Y., Yu, H., & Shen, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712176114 · Cited by 67
“When delivered into targeted cells, Cas9 and sgRNAs encoded by the library introduced loss-of-function indel mutations through nonhomologous end joining (7, 9, 10, 15, 17, 62, 63).”
Background
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.